Transtaganolide G - Compound Card

Transtaganolide G

Select a section from the left sidebar

Transtaganolide G

Structure
Zoomed Structure
  • Family: Plantae - Apiaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Meroterpenoid
Canonical Smiles COC(=O)CC1=C[C@@H]2C(=O)OC3O[C@]41C([C@]23C)CC[C@]([C@@H]4C(=O)O)(C)C=C
InChI InChI=1S/C20H24O7/c1-5-18(2)7-6-12-19(3)11-8-10(9-13(21)25-4)20(12,14(18)15(22)23)27-17(19)26-16(11)24/h5,8,11-12,14,17H,1,6-7,9H2,2-4H3,(H,22,23)/t11-,12?,14+,17?,18+,19+,20-/m1/s1
InChIKey VDZBODVHGVXMCG-QGIJALBHSA-N
Formula C20H24O7
HBA 6
HBD 1
MW 376.41
Rotatable Bonds 4
TPSA 99.13
LogP 2.07
Number Rings 4
Number Aromatic Rings 0
Heavy Atom Count 27
Formal Charge 0
Fraction CSP3 0.65
Exact Mass 376.15
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Thapsia transtagana Apiaceae Plantae 512634

Showing of synonyms

  • Rubala JJ, Moreno-Dorado FJ, et al. (2007). A pyran-2-one and four meroterpenoids from Thapsia transtagana and their implication in the biosynthesis of transtaganolides. Phytochemistry,2007,68(19),2480-2486. [View]
Pubchem: 163038469

No compound-protein relationship available.

Structure

SMILES: O1C2OC(=O)C(C=C3)C2C(C134)CCCC4

Level: 0

Mol. Weight: 376.41 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.97
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-5.040
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-1.98

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.440
Plasma Protein Binding
65.51
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
5.320
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
0.020
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.590
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
2.960
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
0.870
Rat (Acute)
2.210
Rat (Chronic Oral)
1.680
Fathead Minnow
3.910
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
414.320
Hydration Free Energy
-5.440
Log(D) at pH=7.4
0.430
Log(P)
2.3
Log S
-2.69
Log(Vapor Pressure)
-10.28
Melting Point
185.75
pKa Acid
3.99
pKa Basic
4.18
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7472
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7472
Methionine aminopeptidase 2 P9WK19 MAP12_MYCTU Mycobacterium tuberculosis 3 0.7046
Methionine aminopeptidase 2 P9WK19 MAP12_MYCTU Mycobacterium tuberculosis 3 0.7046

Download SDF